查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1476331

到 2030 年射频消融设备的全球市场预测：按产品、模式、应用、最终用户和地区进行分析

Radiofrequency Ablation Devices Market Forecasts to 2030 - Global Analysis By Product, Modality, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球射频消融设备市场规模为 48.7 亿美元，预计到 2030 年将达到 114.1 亿美元，预测期内复合年增长率为 12.9%。

射频消融设备是医疗程序中使用的微创工具，用于治疗慢性疼痛和心律不整等某些疾病。这些设备使用高频电流产生热量，直接作用于特定的组织和神经，有效地破坏它们。与传统手术方法相比，RFA 手术因其准确性、微创性和恢復时间短而受到青睐。

根据世界卫生组织2021年全球卫生支出资料库，德国将国内生产总值（GDP）的12.8%用于医疗保健，英国为11.9%，瑞典为11.3%，挪威为10.1%，义大利为9.5%。

慢性病增加

癌症和心血管疾病等慢性病的盛行率不断上升，推动了对射频消融设备的需求。这些设备提供了一种微创解决方案来治疗与这些疾病相关的慢性疼痛和衰弱症状。随着人口老化和慢性病变得更加普遍，对有效治疗方案的需求也随之增加。射频消融治疗正在推动市场成长，因为它为患者提供了传统手术的可行替代方案，从而缩短了住院时间、加快了康復时间并提高了生活品质。

併发症的风险

RFA 设备出现併发症的风险包括感染、神经损伤、出血，在极少数情况下还会损伤附近器官。这些併发症可能会损害患者的信心，由于额外的治疗而增加医疗费用，并导致医疗保健提供者承担法律责任。因此，安全问题可能会阻碍患者接受和医生采用 RFA 程序。有限的采用将限製手术数量并减缓对 RFA 设备的需求，抑制市场成长，影响製造商的产生收入，并抑制市场扩张。

增加患者对微创手术的偏好

患者越来越多地寻求减少术后併发症、缩短恢復时间并儘量减少不适的手术。射频消融为治疗各种医疗状况提供了传统手术技术的微创替代方案，满足了患者对微创选择的需求。因此，随着医疗保健提供者努力满足患者对更方便、更安全且恢復时间更短的治疗方法的偏好，射频消融设备市场正在经历成长。

与替代疗法的竞争

射频消融的替代治疗方法包括药物治疗、物理治疗和微创治疗，例如冷冻解冻和雷射消融。此类替代疗法的竞争可以为患者和医疗保健提供者提供管理病情的新选择，从而减少需求。此外，一些替代疗法比射频消融具有更低的前期成本和更低的感知风险，这使得它们对某些患者和卫生系统更具吸引力，从而限制了射频消融的市场潜力。

COVID-19 的影响

COVID-19 的爆发对射频消融设备市场产生了各种影响。最初由于封锁和限製而造成的中断导致选择性手术和设备销售下降，但医疗服务的逐步恢復和微创治疗的优先化正在支持市场的復苏。此外，此次疫情凸显了微创治疗对于最大程度地减少患者住院时间和减轻医疗保健系统负担的重要性，从而有利于在后疫情时代进一步普及射频消融术设备。

预计POLA市场在预测期内将是最大的

POLA市场预计将出现良好成长。这些设备是最先进的工具，用于微创手术治疗各种医疗状况。多极射频消融术使用多个电极来创建更广泛和受控的热消融区域。该技术可以精确地瞄准组织，同时最大限度地减少对周围区域的损害。多极射频消融在肝癌、肺癌、慢性疼痛等治疗中显示出良好的效果。其多功能性和有效性使其成为现代介入放射学和肿瘤学实践中的宝贵工具。

预计疼痛管理产业在预测期内复合年增长率最高

疼痛管理领域预计在预测期内将出现最高的复合年增长率，因为它为慢性疼痛提供微创缓解。这些设备使用射频波来瞄准并惰性传输疼痛讯号的特定神经。 RFA 透过精确地瞄准神经而不损伤周围组织，为手术和药物治疗提供了低风险的替代方案。由于其有效性、最短的恢復时间以及改善患者生活品质的能力，RFA 设备已成为疼痛管理领域的重要工具。

比最大的地区

由于慢性病盛行率不断上升、医疗保健成本不断上升以及对微创治疗的认识不断提高，预计亚太地区将在预测期内占据最大的市场占有率。中国、印度和日本等国家是这一成长的主要贡献者，这得益于大量的患者群体和医疗保健服务的改善。此外，新兴国家医疗保健基础设施和技术采用的进步进一步推动了需求。

复合年增长率最高的地区：

由于先进的医疗基础设施和有利的报销政策，预计北美在预测期内将呈现最高的复合年增长率。美国由于其庞大的患者群体和在医疗保健研发方面的大量投资而在该地区市场占据主导地位。技术的进步和微创手术的不断采用进一步促进了市场的成长。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球射频消融设备市场：按产品

  • 射频消融术发生器
  • 射频消融术导管
  • 射频消融术探头
  • 射频消融术配件
  • 其他产品

第六章全球射频消融设备市场：依方式分类

  • 单极结构
  • 双极性
  • 多极

第七章全球射频消融设备市场：依应用分类

  • 心臟病学
  • 肿瘤学
  • 疼痛管理
  • 妇科
  • 泌尿系统
  • 整形外科
  • 美丽
  • 其他用途

第八章全球射频消融设备市场：依最终用户分类

  • 医院
  • 门诊手术中心
  • 专科诊所
  • 研究机构
  • 其他最终用户

第九章全球射频消融设备市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Medtronic PLC
  • Boston Scientific Corporation
  • Abbott Laboratories
  • AngioDynamics Inc.
  • Johnson & Johnson
  • Stryker Corporation
  • Merit Medical Systems Inc.
  • Royal Philips
  • Olympus Corporation
  • Hologic Inc.
  • Cosman Medical
  • RF Medical Corporation
  • Misonix Inc.
  • Neomed Management AS
  • Diros Technology Inc.
  • Compal Electronics
  • Smith & Nephew PLC
  • Elekta AB
  • CONMED Corporation
  • AtriCure
Product Code: SMRC25877

According to Stratistics MRC, the Global Radiofrequency Ablation Devices Market is accounted for $4.87 billion in 2023 and is expected to reach $11.41 billion by 2030 growing at a CAGR of 12.9% during the forecast period. Radiofrequency ablation devices are minimally invasive tools used in medical procedures to treat certain conditions like chronic pain or abnormal heart rhythms. These devices use high-frequency electrical currents to generate heat, which is directed to specific tissues or nerves, effectively destroying them. RFA procedures are often preferred for their precision, minimal invasiveness, and shorter recovery times compared to traditional surgical methods.

According to the WHO Global Health Expenditure Database 2021, Germany spent 12.8% of its Gross Domestic Product (GDP) on healthcare, the UK spent 11.9%, Sweden spent 11.3%, Norway spent 10.1%, and Italy spent 9.5%.

Market Dynamics:

Driver:

Rising incidences of chronic diseases

The increasing prevalence of chronic diseases, such as cancer and cardiovascular conditions, drives the demand for radiofrequency ablation devices. These devices offer minimally invasive solutions for treating chronic pain and debilitating symptoms associated with these diseases. As the aging population grows and chronic conditions become more prevalent, there is a heightened need for effective treatment options. Radiofrequency ablation procedures provide patients with a viable alternative to traditional surgery, leading to reduced hospital stays, faster recovery times, and improved quality of life, thus fueling market growth.

Restraint:

Risk of complications

The risks of complications in RFA devices include infection, nerve damage, bleeding, and rarely, damage to nearby organs. These complications can undermine patient confidence, increase healthcare costs due to additional treatments, and lead to legal liabilities for healthcare providers. Consequently, concerns regarding safety may deter patient acceptance and physician adoption of RFA procedures. Limited adoption hampers market growth by restraining procedure volumes and slowing the demand for RFA devices, impacting revenue generation for manufacturers and impeding market expansion.

Opportunity:

Growing patient preference for minimally invasive procedures

Patients increasingly seek procedures that offer reduced post-operative complications, quicker recovery times, and minimal discomfort. Radiofrequency ablation provides a minimally invasive alternative to traditional surgical methods for treating various medical conditions, fulfilling patient demand for less invasive options. As a result, the market for radiofrequency ablation devices experiences growth as healthcare providers strive to meet patient preferences for procedures that offer greater convenience, safety, and shorter recovery periods.

Threat:

Competition from alternative treatment options

Alternative treatment options to radiofrequency ablation devices include medication, physical therapy, and other minimally invasive procedures such as cryoablation and laser ablation. Competition from these alternatives offers patients and healthcare providers with additional choices for managing conditions, potentially diverting the demand. Additionally, some alternative treatments have lower upfront costs or perceived risks compared to radiofrequency ablation, making them more attractive options for certain patients or healthcare systems, thereby limiting the market potential for radiofrequency ablation devices.

Covid-19 Impact

The covid-19 pandemic has had a mixed impact on the radiofrequency ablation devices market. While the initial disruption caused by lockdowns and restrictions led to a decline in elective procedures and device sales, the gradual resumption of healthcare services and the prioritization of minimally invasive treatments have supported market recovery. Additionally, the pandemic has underscored the importance of less invasive procedures to minimize patient hospital stays and reduce the burden on healthcare systems, potentially driving further adoption of radiofrequency ablation devices in the post-pandemic era.

The multipolar segment is expected to be the largest during the forecast period

The multipolar segment is estimated to have a lucrative growth. These devices are cutting-edge tools used in minimally invasive procedures to treat various medical conditions. Multipolar RFA employs multiple electrodes to create a more extensive and controlled thermal ablation zone. This technology enables precise targeting of tissues while minimizing damage to surrounding areas. Multipolar RFA has shown promising results in treating conditions such as liver cancer, lung tumours, and chronic pain. Its versatility and efficacy make it a valuable tool in modern interventional radiology and oncology practices.

The pain management segment is expected to have the highest CAGR during the forecast period

The pain management segment is anticipated to witness the highest CAGR growth during the forecast period, due to its minimally invasive relief for chronic pain. These devices employ radiofrequency waves to target and deactivate specific nerves that transmit pain signals. By precisely targeting nerves without damaging surrounding tissue, RFA offers a low-risk alternative to surgery and medication. Its effectiveness, minimal recovery time, and ability to improve patients' quality of life make RFA devices indispensable tools in the field of pain management.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period due to increasing prevalence of chronic diseases, rising healthcare expenditure, and growing awareness about minimally invasive treatments. Countries like China, India, and Japan are key contributors to this growth, supported by a large patient population and improving access to healthcare services. Additionally, advancements in healthcare infrastructure and technology adoption in emerging economies further bolster demand.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to its advanced healthcare infrastructure, and favourable reimbursement policies. The United States dominates the region's market due to its large patient population and significant investments in healthcare R&D. Technological advancements and increasing adoption of minimally invasive procedures further contribute to market growth.

Key players in the market

Some of the key players profiled in the Radiofrequency Ablation Devices Market include Medtronic PLC, Boston Scientific Corporation, Abbott Laboratories, AngioDynamics Inc., Johnson & Johnson, Stryker Corporation, Merit Medical Systems Inc., Royal Philips, Olympus Corporation, Hologic Inc., Cosman Medical, RF Medical Corporation, Misonix Inc., Neomed Management AS, Diros Technology Inc., Compal Electronics, Smith & Nephew PLC, Elekta AB, CONMED Corporation and AtriCure.

Key Developments:

In April 2023, Taiwanese electronics company, Compal Electronics has expanded into the therapeutic medical device segment by introducing a new radiofrequency ablation (RFA) system called AblatePal. The new RFA system is intended for use in coagulation and ablation of soft tissue during percutaneous and intraoperative procedures, including partial or complete ablation of non-resectable liver lesions.

In April 2022, Royal Philips launched the latest release of its KODEX-EPD system, which offers enhanced imaging and mapping capabilities for RF ablation, including the new Tissue Engagement Viewer and support for Medtronic DiamondTemp ablation system.

Products Covered:

  • Radiofrequency Ablation Generators
  • Radiofrequency Ablation Catheters
  • Radiofrequency Ablation Probes
  • Radiofrequency Ablation Accessories
  • Other Products

Modalities Covered:

  • Unipolar
  • Bipolar
  • Multipolar

Applications Covered:

  • Cardiology
  • Oncology
  • Pain Management
  • Gynaecology
  • Urology
  • Orthopaedics
  • Cosmetology
  • Other Applications

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Radiofrequency Ablation Devices Market, By Product

  • 5.1 Introduction
  • 5.2 Radiofrequency Ablation Generators
  • 5.3 Radiofrequency Ablation Catheters
  • 5.4 Radiofrequency Ablation Probes
  • 5.5 Radiofrequency Ablation Accessories
  • 5.6 Other Products

6 Global Radiofrequency Ablation Devices Market, By Modality

  • 6.1 Introduction
  • 6.2 Unipolar
  • 6.3 Bipolar
  • 6.4 Multipolar

7 Global Radiofrequency Ablation Devices Market, By Application

  • 7.1 Introduction
  • 7.2 Cardiology
  • 7.3 Oncology
  • 7.4 Pain Management
  • 7.5 Gynaecology
  • 7.6 Urology
  • 7.7 Orthopaedics
  • 7.8 Cosmetology
  • 7.9 Other Applications

8 Global Radiofrequency Ablation Devices Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Ambulatory Surgical Centers
  • 8.4 Specialty Clinics
  • 8.5 Research Institutes
  • 8.6 Other End Users

9 Global Radiofrequency Ablation Devices Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Medtronic PLC
  • 11.2 Boston Scientific Corporation
  • 11.3 Abbott Laboratories
  • 11.4 AngioDynamics Inc.
  • 11.5 Johnson & Johnson
  • 11.6 Stryker Corporation
  • 11.7 Merit Medical Systems Inc.
  • 11.8 Royal Philips
  • 11.9 Olympus Corporation
  • 11.10 Hologic Inc.
  • 11.11 Cosman Medical
  • 11.12 RF Medical Corporation
  • 11.13 Misonix Inc.
  • 11.14 Neomed Management AS
  • 11.15 Diros Technology Inc.
  • 11.16 Compal Electronics
  • 11.17 Smith & Nephew PLC
  • 11.18 Elekta AB
  • 11.19 CONMED Corporation
  • 11.20 AtriCure

List of Tables

  • Table 1 Global Radiofrequency Ablation Devices Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Radiofrequency Ablation Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Radiofrequency Ablation Devices Market Outlook, By Radiofrequency Ablation Generators (2021-2030) ($MN)
  • Table 4 Global Radiofrequency Ablation Devices Market Outlook, By Radiofrequency Ablation Catheters (2021-2030) ($MN)
  • Table 5 Global Radiofrequency Ablation Devices Market Outlook, By Radiofrequency Ablation Probes (2021-2030) ($MN)
  • Table 6 Global Radiofrequency Ablation Devices Market Outlook, By Radiofrequency Ablation Accessories (2021-2030) ($MN)
  • Table 7 Global Radiofrequency Ablation Devices Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 8 Global Radiofrequency Ablation Devices Market Outlook, By Modality (2021-2030) ($MN)
  • Table 9 Global Radiofrequency Ablation Devices Market Outlook, By Unipolar (2021-2030) ($MN)
  • Table 10 Global Radiofrequency Ablation Devices Market Outlook, By Bipolar (2021-2030) ($MN)
  • Table 11 Global Radiofrequency Ablation Devices Market Outlook, By Multipolar (2021-2030) ($MN)
  • Table 12 Global Radiofrequency Ablation Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 13 Global Radiofrequency Ablation Devices Market Outlook, By Cardiology (2021-2030) ($MN)
  • Table 14 Global Radiofrequency Ablation Devices Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 15 Global Radiofrequency Ablation Devices Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 16 Global Radiofrequency Ablation Devices Market Outlook, By Gynaecology (2021-2030) ($MN)
  • Table 17 Global Radiofrequency Ablation Devices Market Outlook, By Urology (2021-2030) ($MN)
  • Table 18 Global Radiofrequency Ablation Devices Market Outlook, By Orthopaedics (2021-2030) ($MN)
  • Table 19 Global Radiofrequency Ablation Devices Market Outlook, By Cosmetology (2021-2030) ($MN)
  • Table 20 Global Radiofrequency Ablation Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 21 Global Radiofrequency Ablation Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 22 Global Radiofrequency Ablation Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 23 Global Radiofrequency Ablation Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 24 Global Radiofrequency Ablation Devices Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 25 Global Radiofrequency Ablation Devices Market Outlook, By Research Institutes (2021-2030) ($MN)
  • Table 26 Global Radiofrequency Ablation Devices Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.